Business Description
Avecho Biotechnology Ltd
ISIN : AU0000047441
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 21.7 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.07 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -45.57 | |||||
Beneish M-Score | -6.99 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 0.09 | |||||
6-1 Month Momentum % | -60 | |||||
12-1 Month Momentum % | 500 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.54 | |||||
Quick Ratio | 3.48 | |||||
Cash Ratio | 3.04 | |||||
Days Inventory | 81.03 | |||||
Days Sales Outstanding | 352.91 | |||||
Days Payable | 530.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.6 | |||||
Shareholder Yield % | -57.03 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 0.8 | |||||
Operating Margin % | -1000.2 | |||||
Net Margin % | -699.6 | |||||
FCF Margin % | -688.22 | |||||
ROE % | -81.72 | |||||
ROA % | -61.1 | |||||
ROIC % | -441.58 | |||||
ROC (Joel Greenblatt) % | -1099.58 | |||||
ROCE % | -79.59 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3 | |||||
EV-to-EBIT | -1.41 | |||||
EV-to-EBITDA | -1.47 | |||||
EV-to-Revenue | 9.82 | |||||
EV-to-FCF | -1.44 | |||||
Earnings Yield (Greenblatt) % | -70.92 | |||||
FCF Yield % | -35.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AVEFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Avecho Biotechnology Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.331 | ||
EPS (TTM) ($) | -0.001 | ||
Beta | 4.49 | ||
Volatility % | 1406.72 | ||
14-Day RSI | 0.09 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 0.0012 | ||
12-1 Month Momentum % | 500 | ||
52-Week Range ($) | 0.0002 - 0.003 | ||
Shares Outstanding (Mil) | 3,169.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Avecho Biotechnology Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Avecho Biotechnology Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Avecho Biotechnology Ltd Frequently Asked Questions
What is Avecho Biotechnology Ltd(AVEFF)'s stock price today?
When is next earnings date of Avecho Biotechnology Ltd(AVEFF)?
Does Avecho Biotechnology Ltd(AVEFF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |